SCHEMBL7573958

SCHEMBL7573958

OC(COc1ccc(-c2occ3cc(F)ccc23)cc1)CN1CCC(O)(c2ccc(Cl)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 8/20 0.48
KCNH2 Q12809 6/20 0.48
DRD2 P14416 4/20 0.48
DRD3 P35462 3/20 0.48
HTR1A P08908 1/20 0.48
DRD1 P21728 1/20 0.48
DRD5 P21918 1/20 0.48
SLC6A2 P23975 1/20 0.48
HTR2A P28223 1/20 0.48
SLC6A4 P31645 1/20 0.48
HTR7 P34969 1/20 0.48
HRH1 P35367 1/20 0.48
HTR2B P41595 1/20 0.48
SSTR5 P35346 1/20 0.42
SIGMAR1 Q99720 3/20 0.41
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
RECQL P46063 1/20 0.41
DRD4 P21917 1/20 0.41
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1382258 0.83 ATM (0.56) RECQLKMT2A
SCHEMBL11813239 0.83 CACNA1G (0.68) CACNA1GKCNH2DRD2DRD3HTR1A
SCHEMBL7572169 0.82 PKM (0.57) LMNAMAPK1KMT2A
SCHEMBL7572390 0.82 KDM4E (0.58) CACNA1GKCNH2LMNAKMT2A
SCHEMBL5364873 0.81 CACNA1G (0.48) CACNA1GKCNH2DRD2DRD3HTR1A
SCHEMBL5366673 0.81 CACNA1G (0.48) CACNA1GKCNH2DRD2DRD3HTR1A
SCHEMBL5364880 0.81 CACNA1G (0.48) CACNA1GKCNH2DRD2DRD3HTR1A
SCHEMBL7564076 0.81 PKM (0.43) CACNA1GHTR1AKMT2A
SCHEMBL11811581 0.80 KCNH2 (0.64) CACNA1GKCNH2DRD2DRD3HTR1A
SCHEMBL1382380 0.79 DRD2 (0.53) CACNA1GKCNH2DRD2DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216244-A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists Aventis Pharmaceuticals Inc. (US) 2002-06-26 EP disclosed
WO-2001019821-A1 BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2001-03-22 WO disclosed